West extends ready-to-sterilise service to Europe, Asia
West Pharmaceutical Services is rolling out its Westar RS sterilized component service, formerly only available from its US facilities, at sites in France, Germany and Singapore.
West Pharmaceutical Services is rolling out its Westar RS sterilized component service, formerly only available from its US facilities, at sites in France, Germany and Singapore.
Transgenomic has taken out a non-exclusive licence from Geron in which it gains manufacturing rights to phosphoramidate and thio-phosphoramidate oligonucleotides.
The UK BioIndustry Association has serious concerns that the EU Clinical Trials Directive could have a negative impact on the attractiveness of the UK as a location for clinical research.
Two members of GlaxoSmithKline's remuneration committee have resigned in the wake of the company's defeat by shareholders over its pay policy.
Pharmaceutical company mergers and acquisitions plus industry-wide cost cutting has squeezed investment into manufacturing, which may lead to GMP non-compliance and fines, warns a new report.
Boston Biomedica has been issued an additional US patent covering the design and use of its Pressure Cycling Technology for the control of pressure-sensitive chemical reactions.
Patheon Italia has extended its manufacturing services agreement with Roche to continue to supply the Swiss firm with solid, liquid and sterile products for the European market.